vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · IEX Real-Time Price · USD
+1.23 (5.80%)
At close: Jun 13, 2024, 3:09 PM
+0.29 (1.31%)
After-hours: Jun 13, 2024, 4:00 PM EDT

vTv Therapeutics Revenue

vTv Therapeutics had revenue of $1.00M in the twelve months ending March 31, 2024, with 5,455.56% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $1.00M.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
55.49M USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 20230--
Dec 31, 20222.02M-1.99M-49.61%
Dec 31, 20214.01M-2.41M-37.56%
Dec 31, 20206.41M3.65M132.05%
Dec 31, 20192.76M-9.67M-77.77%
Dec 31, 201812.43M12.14M4,172.85%
Dec 31, 2017291.00K-343.00K-54.10%
Dec 31, 2016634.00K115.00K22.16%
Dec 31, 2015519.00K-1.03M-66.49%
Dec 31, 20141.55M573.00K58.71%
Dec 31, 2013976.00K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
NeueHealth 1.11B
Inotiv 552.74M
CareCloud 113.02M
Daxor 34.67M
CASI Pharmaceuticals 33.88M
Ocuphire Pharma 19.01M
Lexaria Bioscience 386.00K
Revenue Rankings